Unpredictable communication and a lack of transparency are eroding the industry’s and the public’s trust. The FDA, experts ...
Penn and CHOP researchers want to develop urea cycle disorder treatments using CRISPR gene-editing therapy. Get unlimited access to Inquirer.com and The Inquirer App, plus 5 articles each month to ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
Marty Makary and Vinay Prasad offered a roadmap for expanding access to custom gene-editing treatments like the one used to ...
The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on ...
Worldwide Healthcare Trust PLC - Half-year Financial Report PR Newswire LONDON, United Kingdom, November 13 LONDON STOCK EXCHANGE ANNOUNCEMENT Worldwide ...
Positive 9-month follow-up data for NDV-01 showed a 92% overall response rate at any time in non-muscle invasive bladder cancer (NMIBC), with favorable overall safety ...
A sponsor will have to demonstrate success with "with several consecutive patients with different bespoke therapies" to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback